20 DECEMBER 2012 NEW ZEALAND GAZETTE, No. 151

4473

and Veterinary Medicines Act 1997 (“the Act”), that the following application has been made to register a trade name product under section 9(1) of the Act:

Trade Name: Mycofix Plus 3.E

Reference: A010855

Active Ingredients and Concentrations:

• Diatomaceous Earth 250g/kg
• Bentonite 300g/kg, Inactivated Yeast 300g/kg

Formulation Type: Powder

General Use Claim: For management of adverse effects that may result from mycotoxin contaminants that may be present in stock foods for poultry, pigs, sheep and cattle.

Any person may make a written submission to the director-general concerning this application.

Under sections 16 and 17 of the Act, a written submission:

(a) must state in full the reasons for making the submission; and

(b) may state any decision sought on that application; and

(c) must be received by the director-general no later than 30 working days after the date of notification in the New Zealand Gazette.

Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.

The following address is:

(a) where submissions on this application are to be sent; and

(b) where requests for copies of the public information relating to the application can be sent; and

(c) where public information relating to the application can be viewed; and

(d) the director-general’s address for service:

ACVM Group, Ministry for Primary Industries,
Pastoral House, 25 The Terrace, Wellington 6011.
Postal Address: PO Box 2526, Wellington 6140.

The applicant’s address for service is:
Biomin Australia Pty Limited, 25/9–15 Lloyds Avenue,
Airport Oaks, Carlingford New South Wales 2118, Australia.
Postal Address: PO Box 2344, Carlingford,
New South Wales 2118, Australia.

Dated at Wellington this 17th day of December 2012.

MAREE ZINZLEY, Manager (Approvals Operations),
Ministry for Primary Industries (acting under delegated authority).

go8449

Notice of Application to Register a Trade Name Product (Notice No. MPI 120)

Maree Zinzley, Manager (Approvals Operations) of the Ministry for Primary Industries (MPI), acting under delegated authority from the Director-General of MPI, gives notice, under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“the Act”), that the following application has been made to register a trade name product under section 9(1) of the Act:

Trade Name: IR6 B12 + Se for Ewes

Reference: A010781

Active Concentrations and Ingredients:
Each 2mL dose contains Hydroxocobalamin acetate (Vitamin B12) 2mg, Selenium 5mg and a fluid suspension of treated, purified toxoids of Clostridium septicum, Clostridium perfringens type D, Clostridium tetani, Clostridium sordellii and Clostridium novyi type B, combined with the formol-treated cells of Clostridium chauvoei. Also contains ≤ 0.1% thiomersal.

Formulation Type: Aqueous suspension

General Use Claim: For the active immunisation of sheep against the 6 most common Clostridial diseases in sheep: Pulpy Kidney (PK), Tetanus, Blackleg, Malignant Oedema, Black Disease and Sudden Death Syndrome (caused by Clostridium sordellii).

Any person may make a written submission to the director-general concerning this application.

Under sections 16 and 17 of the Act, a written submission:

(a) must state in full the reasons for making the submission; and

(b) may state any decision sought on that application; and

(c) must be received by the director-general no later than 30 working days after the date of notification in the New Zealand Gazette.

Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.

The following address is:

(a) where submissions on this application are to be sent; and

(b) where requests for copies of the public information relating to the application can be sent; and

(c) where public information relating to the application can be viewed; and

(d) the director-general’s address for service:

ACVM Group, Ministry for Primary Industries,
Pastoral House, 25 The Terrace, Wellington 6011.
Postal Address: PO Box 2526, Wellington 6140.

The applicant’s address for service is:
Bayer New Zealand Limited, 3 Argus Place, Hillcrest,
Auckland 1024.
Postal Address: PO Box 2825, Shortland Street, Auckland 1140.

Dated at Wellington this 18th day of December 2012.

MAREE ZINZLEY, Manager (Approvals Operations),
Ministry for Primary Industries (acting under delegated authority).

go8458

Notice of Application to Register a Trade Name Product (Notice No. MPI 121)

Maree Zinzley, Manager (Approvals Operations) of the Ministry for Primary Industries (MPI), acting under delegated authority from the Director-General of MPI, gives notice, under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“the Act”), that the following application has been made to register a trade name product under section 9(1) of the Act:

Trade Name: IR6 B12 + Se for Lambs

Reference: A010782

Active Concentrations and Ingredients:
Each 2mL dose contains Hydroxocobalamin acetate (Vitamin B12) 1mg, Selenium 2mg and a fluid suspension of treated, purified toxoids of Clostridium septicum, Clostridium perfringens type D, Clostridium tetani, Clostridium sordellii and Clostridium novyi type B, combined with the formol-treated cells of Clostridium chauvoei. Also contains ≤ 0.1% thiomersal.

Formulation Type: Aqueous suspension

General Use Claim: For the active immunisation of sheep against the 6 most common Clostridial diseases in sheep: Pulpy Kidney (PK), Tetanus, Blackleg, Malignant Oedema, Black Disease and Sudden Death Syndrome (caused by Clostridium sordellii).